Endo International plc (NASDAQ: ENDP) shares fell 0.1% to $61.94, after affiliates of the company have acquired worldwide rights to Sumavel® DosePro® (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix, Inc. Share volume was 1.6 million, compared to an all-day average of three million
